ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "takayasu arteritis and treatment"

  • Abstract Number: 811 • 2014 ACR/ARHP Annual Meeting

    Biologics in Takayasu Arteritis: Preliminary Data from the French Registry

    Arsene Mekinian1, Chloe Comarmond2, Mathieu Resche Regon3, Tristan Mirault4, Jean-Emmanuel Kahn5, Marc Lambert6, Jean Sibilia7, Antoine Neel8, Miguel Hié9, Emmanuel Messas10, Pascal Cohen11, Geraldine Muller12, Sabine Berthier13, Zahir Amoura14, Isabelle Marie15, Christian Lavigne16, Marie Anne Vandenhende17, Hervé Devilliers18, Sébastien Abad19, Loic Guillevin20, Mohamed Hamidou21, Bertrand Godeau22, Patrice Cacoub23, Olivier Fain24 and David Saadoun2, 1DHU2iB, Internal Medicine Saint Antoine Hospital, PARIS, France, 2DHU 2iB Internal Medicine Referal Center for Autoimmune diseases Pitie Hospital, Paris, France, 3biostatistics Saint Louis Hospital, paris, France, 4HEGP vascular department, paris, France, 5Internal Medicine, Foch Hospital, Suresnes, France, 6Faculté de Médecine Henri Warembourg, Université Lille Nord de France, Lille, France, 7Division of Rheumatology, University Hospital of Strasbourg, Strasbourg, France, 8INTERNAL MEDICINE, NANTES, France, 9Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France, 10HEGP hospital Vascular and cardiology Department, paris, France, 11National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, 12INTERNAL MEDICINE, DIJON, France, 13DIJON HOSPITAL, DIJON, France, 14Internal medicine 2, French National Reference Center for Systemic Lupus and Antiphospholipid Syndrome, Pitié-Salpêtrière Hospital (AP-HP), Paris, France, 15CHU de Rouen, Rouen, France, 16CHU d'Angers, Angers, France, 17Internal Medicine, Bordeaux, France, 18Dijon University Hospital, Department of internal medicine and systemic diseases, Dijon, France, 19Hôpital Avicenne, Bobigny, France, 20Internal Medicine, Service de médecine interne, Centre de Références des Vascularites, Université Paris Descartes, APHP, Hôpital Cochin, 75005 Paris, France., Paris, France, 21CHU Hôtel Dieu, Nantes, Nantes, France, 22Service de médecine interne, Université Paris Est Créteil, AP-HP, Hôpital Mondor Créteil, France, Service de médecine interne, Université Paris Est Créteil, AP-HP, Hôpital Mondor Créteil, France, Creteil, France, 23Groupe Hospitalier Pitié Salpétrière, Service de Médecine Interne, DHU i2B, Paris, France, 24Hôpital Saint Antoine, DHU i2B, Service de Médecine Interne, paris, France

    Background/Purpose The aim of this registry is to determine: (1) the real-life use of various biological targeted treatments in Takayasu arteritis (TA) in France; (2)…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology